In addition, S100A9 gene deficiency inhibits pyroptosis of macrophages through TLR4/MyD88/NF-κB pathway, alleviating LPS-induced acute lung injury (157), which suggests a potential therapeutic strategy for the treatment of ALI/ARDS. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.